FDA approves Teva's generic version of Aciphex

02/22/2007 | Globes (Israel)

The FDA approved Teva Pharmaceutical Industries Ltd.'s generic version of Aciphex, an acid pump inhibitor made by Japan's Eisai Co. Ltd., a product with annual sales of $1.3 billion. A suit by Eisai against Teva over the drug's patent is pending in federal court in New York.

View Full Article in:

Globes (Israel)

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Compliance and Ethics Director
Sysmex America, Inc.
Lincolnshire, IL
Director, Site Quality Management
CareFusion
Palm Springs, CA
Compliance Officer-Medical Products
W. L. Gore
Flagstaff, AZ
Project Manager RA - 15000003MD
Abbott
Santa Clara, CA
Director, Site Quality Management
CareFusion
Minneapolis, MN